open access

Vol 65, No 1 (2015)
Invited editorial
Published online: 2015-03-06
Get Citation

Evolution of systemic anti-cancer treatment

Maciej Krzakowski
DOI: 10.5603/NJO.2015.0001
·
Nowotwory. Journal of Oncology 2015;65(1):1-6.

open access

Vol 65, No 1 (2015)
Invited editorial
Published online: 2015-03-06

Abstract

Tailored to clinical and molecular characteristics of a patient’s management is the most promising direction in the evolution of systemic anti-cancer treatment. Recent observations show, that significant progress may be also rela­ted to the use of methods addressing the immune system of patients. The use of multidisciplinary management is important since, that represents combined administration of various pharmacological treatments as well as the use of loco-regional and systemic methods. The aim of this paper is to discuss the most important ways in the evolution of systemic anti-cancer treatment.

Abstract

Tailored to clinical and molecular characteristics of a patient’s management is the most promising direction in the evolution of systemic anti-cancer treatment. Recent observations show, that significant progress may be also rela­ted to the use of methods addressing the immune system of patients. The use of multidisciplinary management is important since, that represents combined administration of various pharmacological treatments as well as the use of loco-regional and systemic methods. The aim of this paper is to discuss the most important ways in the evolution of systemic anti-cancer treatment.

Get Citation
About this article
Title

Evolution of systemic anti-cancer treatment

Journal

Nowotwory. Journal of Oncology

Issue

Vol 65, No 1 (2015)

Article type

Invited editorial

Pages

1-6

Published online

2015-03-06

DOI

10.5603/NJO.2015.0001

Bibliographic record

Nowotwory. Journal of Oncology 2015;65(1):1-6.

Authors

Maciej Krzakowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl